Skip to main content
OpenTrials
Completed

NCT Number: NCT01549145

Sub-chronic Neurostimulation Delivered in the Middle Ear for Tinnitus Suppression

The objectives of this study are to evaluate the safety and efficacy of applying electrical stimulation on the promontorium (EPS) for the suppression of tinnitus in a sub-chronic stimulation regimen.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Total score on the Handicap Inventory (THI) of at least 40.
  • Visual scale over 5.
  • Tinnitus origin is peripheral (related to long term noise exposure, or to a sudden exposure to a very loud noise etc.)
  • Tinnitus is on-going; present for more than 50% of the time over the past 12 months.
  • Unilateral tinnitus
  • Tinnitus prevalent at least 12 months.
  • Willingness to abstain from part taking in other, non-study procedures indicated to lessen tinnitus and/or its perception.
  • Willing and able to refrain from engaging in activities or work involving loud noise exposure.
  • Male or females 18-60 years of age

Exclusion criteria

  • Prior history of sudden hearing loss and/or fluctuating hearing levels.
  • Tinnitus prevalent more than 3 years.
  • History of frequent middle ear infections
  • Patient under immunosuppressant therapy
  • Auditory nerve damage.
  • Vestibular Schwannoma
  • Cochlear implant.
  • Pregnant or lactating.
  • Developmental disability or cognitive impairment that would make it difficult for the subject to partake in the clinical study, including adequate comprehension of the informed consent form and ability to record the necessary measurements.
  • Involvement in litigation and/or a worker's compensation claim and/or receiving disability benefits related to tinnitus and/or hearing loss.
  • Not being physically or geographically capable of returning for scheduled follow-up visits.
  • Any physical, psychological, or emotional disorder that would interfere with the planned surgical operations
  • Mentally retarded, developmentally delayed or suffering from organic brain dysfunction.

Treatment and study plan

Nimbus Multifunctional Stimulator

Device

A Multifunctional Stimulator (Nimbus by Newmedic, Hemodia) for clinical use. The stimulator is also dedicated for Electrical Promontory Stimulation (EPS)

Primary outcomes

  1. Efficacy

    Time frame: 2 months

    Study efficacy evaluations will be based on the analysis of pre and post procedure tinnitus severity characteristics (THI, MML, Pitch matching and VAS values).

Secondary outcomes

  1. Safety

    Time frame: 2 months

    Safety evaluations will be based on the observation for the reporting of any adverse events occurring during the study and up to the 30 days follow-up visit Occurrence of adverse events.

Sponsors and collaborators

Lead sponsor

EstimME Ltd.

Industry

Registry information

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Mar 9, 2012
Registry last updated
Aug 29, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.